2026 Volume 73 Issue 3.4 Pages 302-309
Focal hand dystonia (FHD) is a task-specific movement disorder characterized by involuntary muscular contractions and aberrant posturing, which engender significant occupational impairment and profoundly diminish quality of life (QOL). Therapeutic interventions such as botulinum toxin (BoNT) and deep brain stimulation (DBS) have demonstrated efficacy in ameliorating motor manifestations of FHD. However, strategies directed toward enhancing QOL and activities of daily living (ADL) in individuals with FHD remain insufficiently elucidated, and their effectiveness necessitates further validation. This narrative review endeavors to integrate contemporary evidence concerning rehabilitative and behavioral interventions for adults with FHD, with particular emphasis on outcomes related to QOL and ADL. A systematic search of PubMed and Scopus (September 20, 2025) yielded eight eligible studies comprising five interventional and three observational designs. The interventional studies demonstrated that cognitive-behavioral therapy, task-specific retraining, multimodal sensorimotor interventions, repetitive transcranial magnetic stimulation-assisted neurorehabilitation, and physiotherapy with stretching and splinting techniques were associated with improvements in self-assessed functioning, QOL, and psychosocial health, though objective motor outcomes were variably affected. Observational investigations consistently demonstrate that depression, fatigue, apathy, and pain exert a more pronounced impact on QOL and ADL than motor symptom severity. These results suggest that rehabilitation strategies may confer benefits not only for motor recovery, but also for ameliorating non-motor symptoms and facilitating psychosocial adaptation. Addressing both motor and non-motor domains through integrated sensorimotor and behavioral strategies may enhance daily functioning and overall well-being in individuals with FHD. Further large-scale, longitudinal studies are warranted to establish standardized, evidence-based rehabilitation programs for this population. J. Med. Invest. 73 : 302-309, August, 2026